Previous Article | Next Article ![]()
Infection and Immunity, January 2001, p. 252-261, Vol. 69, No. 1
Department of Microbiology, University of
Alabama at Birmingham, Birmingham, Alabama
35294,1 and Center for Microbial
Pathogenesis and the Department of Microbiology School of Medicine and
Biomedical Sciences, State University of New York at Buffalo,
Buffalo, New York 142142
Received 6 June 2000/Returned for modification 31 August
2000/Accepted 5 October 2000
The ADP-ribosylating enterotoxins, cholera toxin (CT) and the
Escherichia coli heat-labile toxin (LT-IIa), have been
shown to enhance mucosal and systemic antibody (Ab) responses to
coadministered antigens. The purpose of the present study was to
compare the ability of the nontoxic A2/B subunits of these toxins,
which have distinct targeting properties, to augment the immunogenicity
of a genetically coupled protein antigen. Structurally similar chimeric proteins were generated by genetically replacing the toxic A1 subunit
of CT or LT-IIa with the saliva-binding region (SBR) from the
streptococcal adhesin AgI/II. Intranasal immunization of BALB/c mice
with either chimeric protein induced significantly higher plasma and
mucosal anti-SBR immunoglobulin A (IgA) and IgG Ab responses than SBR
alone. Moreover, compared to SBR-LT-IIaA2/B, SBR-CTA2/B elicited
significantly higher levels of plasma IgG1 and salivary IgA anti-SBR Ab
responses. Ex vivo and in vitro experiments revealed that SBR-CTA2/B
selectively up-regulated B7-2 expression on murine B cells isolated
from both the nasal associated lymphoid tissue, cervical lymph nodes,
and spleen. In contrast, SBR-LT-IIaA2/B had little effect on B7-1 or
B7-2 expression on B220+, CD11b+, or
CD11c+ cells. Analysis of the functional costimulatory
activity of SBR-CTA2/B-treated B cells revealed a significant
enhancement in anti-CD3-stimulated CD4+ T-cell
proliferative responses, and this proliferation was significantly reduced by treatment with anti-B7-2 but not with anti-B7-1 or isotype
control Abs. Thus, SBR-CTA2/B and SBR-LT-IIaA2/B exhibit distinct
patterns of antibody responses associated with differential effects on
B7-2 expression and subsequent costimulatory effects on
CD4+ T cells.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.252-261.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Recombinant Antigen-Enterotoxin A2/B Chimeric
Mucosal Immunogens Differentially Enhance Antibody Responses and
B7-Dependent Costimulation of CD4+ T Cells
*
Corresponding author. Mailing address: Department of
Microbiology, University of Alabama at Birmingham, 845 South 19th St., BBRB 738, Birmingham, AL 35294-2170. Phone: (205) 934-1233. Fax: (205)
934-3894. E-mail: michmart{at}uab.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»